行业研究公司研究宏观策略财报招股书会议纪要 seedance2.0 低空经济 DeepSeek AIGC 大模型

比利时和卢森堡市场月度趋势报告 - 2025年3月

金融 2025-03-01 - 艾昆纬 Derek.

比利时及卢森堡市场趋势（2025年3月）

销售额演变

比利时零售市场总价值：2.4亿欧元。
销售额趋势：2021年3月至2024年3月期间，比利时公共价格销售额呈现波动增长，从1.529亿欧元增长至2.369亿欧元；销售单位量从120.25亿单位增长至232.42亿单位。
近期增长：2024年3月相比2023年3月，销售额在价值上增长6%，单位量增长2%。

消费健康市场增长

市场增长：2023年3月至2024年3月，比利时消费健康（CH）市场价值增长1%，单位量下降2%。
细分市场表现：
- OTC（非处方药）：价值增长1%，单位量下降1%。
- PEC（处方药）：价值下降1%，单位量下降14%。
- PACNTR（患者护理）：价值下降1%，单位量下降6%。

市场份额

OTC市场份额：在总CH市场中，OTC占据68%的单位量和66%的价值份额。
价值分布：OTC占68%，PEC占11%，PACNTR占4%。

前5类产品销售演变

增长最快的类别：
- 疼痛缓解：价值增长2%，单位量增长2%。
- 感冒咳嗽及其他呼吸道产品：价值增长2%，单位量增长0%。
- 消化及其他肠道产品：价值增长3%，单位量增长1%。
- 维生素/矿物质/营养补充剂：价值增长9.2%，单位量增长8.5%。
- 皮肤治疗：价值增长8.5%，单位量增长6.7%。

前10大畅销OTC产品

按单位量排名：
1. 一般疼痛缓解（19,665万单位）
2. 感冒咳嗽产品（11,170万单位）
3. 泻药（7,799万单位）
4. 肌肉疼痛缓解（4,828万单位）
5. 其他特定维生素（3,627万单位）
按价值排名：
1. 一般疼痛缓解（8.1%市场份额）
2. 感冒咳嗽产品（7.799亿欧元）
3. 泻药（6.8亿欧元）
4. 肌肉疼痛缓解（5.967亿欧元）
5. 其他特定维生素（3.6亿欧元）

新兴趋势：增长最快的CH类别

按单位量增长：
1. 婴儿一次性用品及母婴护理（30.3%）
2. 女性美容产品（27.4%）
3. 口腔护理产品（27.5%）
4. 维生素/矿物质/营养补充剂（8.7%）
5. 皮肤治疗（8.1%）
按价值增长：
1. 婴儿食品（39.7%）
2. 女性美容产品（22.2%）
3. 口腔护理产品（9.2%）
4. 维生素/矿物质/营养补充剂（8.5%）
5. 皮肤治疗（8.5%）

© 2025. All rights reserved. IQVIA®is a registered trademark of IQVIA Inc. in the United States, the European Union, and various other countries.March 2025Monthly Belgiumand Luxembourg MarketTrends +Belgium: Retail+Belgium: Consumer Health+Luxembourg: RetailMonthly Belgium and Luxembourg MarketTrends March 2025 Sales Evolution1.0002.0001.5002.50005001.529383392111MAT/03/20221.566394291118MAT/03/2023267115MAT/03/20252.4152.3692.3762.403MAT/03/20241.5924292694201.570117Sales in public price (Mio €)OTCPECPACNTRMonthly Belgium and Luxembourg Market Trends-February 2025-Not to be published without prior consent IQVIASales units (Mio)100501502000The Belgian retail market is worth € 2.4 billionVALUESource:IQVIA–CH Audits–Selling Out data % of growth versus previous MATConsumer Health market growth evolution in BelgiumMonthly Belgium and Luxembourg Market Trends-February 2025-Not to be published without prior consent IQVIA-30-20-10010MAT/03/2023MAT/03/2024MAT/03/2025-2%2%3%-26%6%0%0%7%-8%-1%1%1%2%-1%-2%% of growth in public price vs. previous MATTotal Consumer HealthOTCPECPACNTR% of growth versus previous MAT% of growth in units vs. previous MAT-30,0-27,5-25,0-22,5-20,0-17,5-15,0-12,5-10,0-7,5-5,0-2,50,02,55,07,510,0MAT/03/2024-5%2%-4%-29%-1%-6%-5%-1%-14%-6%MAT/03/2023Total Consumer HealthOTCVALUEUNITSIn the last MAT, in value, the total CH market shows an increase of 01%, while Patient Care declines with-01%and in units, the CH market shows a decrease of-02%, while the OTC declines with-01%Source:IQVIA–CH Audits–Selling Out data MAT/03/2025-2%-1%-2%PEC Monthly Belgium and Luxembourg Market Trends-February 2025-Not to be published without prior consent IQVIAMarket Share5%66%OTC18%PEC11%PACNTRValuePublic price68%15%13%4%OTCPECPACNTRMAT/03/2025MAT/03/2025UnitsOTC segment has a market share of 68% in units and 66% in value of the totalCH marketSource:IQVIA–CH Audits–Selling Out data % of growth versus last MATTop 5 classes sales evolutionMonthly Belgium and Luxembourg Market Trends-February 2025-Not to be published without prior consent IQVIA-30-25-20-15-10-505101520MAT/03/2023MAT/03/2024MAT/03/2025% of growth in public price vs. previous MAT02 PAIN RELIEF01 COUGH COLD&OTH RESP PROD04 VIT/MINERALS/NUTRIT.SUPPL03 DIGEST & OTH INTEST PROD06 SKIN TREATMENTVALUE Top 10 Best Selling OTC2 classes in retailUNITS (= number of packs)The top 10 bestsellingOTC2 classes in CH in units andvalueMonthly Belgium and Luxembourg Market Trends-February 2025-Not to be published without prior consent IQVIATop 10 Best Selling OTC2 classes in retailVALUE public pricePub/EURMAT/03/2025196 M €% of BECH Market8.1%100 M €4.2%86 M €3.6%85 M €3.5%80 M €3.3%69 M €2.9%66 M €2.8%65 M €2.7%65 M €2.7%63 M €2.6%02A GENERAL PAIN RELIEF01B COLD REMEDIES07A EYE CARE01A COUGH PRODUCTS04F MINERAL SUPPLEMENTS35G MILK PRDS FOR CHILDREN03C LAXATIVES02E MUSCULAR PAIN RELIEF04E OTHER SPECIFIC VITAMINSUNMAT/03/202519,665,126% of BECH Market11,170,9987,799,9245,967,2655,171,0184,827,9694,076,3623,327,2123,079,5503,003,87502A GENERAL PAIN RELIEF01B COLD REMEDIES01A COUGH PRODUCTS01C SORE THROAT REMEDIES07A EYE CARE03C LAXATIVES04E OTHER SPECIFIC VITAMINS02E MUSCULAR PAIN RELIEF04F MINERAL SUPPLEMENTS03D ANTIDIARRHOEALSSource:IQVIA–CH Audits–Selling Out data13A CALMING AND SLEEPINGPRODUCTS Fastest Growing OTC1 in Rx salesin % growth in UNITSEmerging Trends: Top 10 Consumer Health classes showingGrowth in Units and ValueMonthly Belgium and Luxembourg Market Trends-February 2025-Not to be published without prior consent IQVIAFastest Growing OTC1 in Rx salesin % growth in VALUE ex-mnfPub/EURMAT/03/20254 K €Absolutegrowthin value1 K €7 K €2 K €1193 K €264 K €3545 K €325 K €2814 K €240 K €21142 K €1802 K €24 K €2 K €358 K €23 K €75158 K €4652 K €1824 K €109 K €54 BABY DISPOSABLE & CH ENU82 BEAUTY PRODUCT FOR WOMEN09 MOUTH TREATMENT PRODUCTS06 SKIN TREATMENT37 CONFECTIONERY04 VIT/MINERALS/NUTRIT.SUPPL%growth39.7%27.5%22.2%9.2%8.5%8.5%6.7%6.3%6.2%6.0%UNMAT/03/2025193Absolutegrowth in units585731579281,9561592,099,180143,644130,9567,5663,791,410186,75691,9043,534214,6516,02233 FIBRE FOOD PRODUCTS65 BABY+NURSING ACCESSORIES79 OTHER PATIENT ARE PRODS35 BABY FOODS82 BEAUTY PRODUCT FOR WOMEN09 MOUTH TREATMENT PRODUCTSSource:IQVIA–CH Audits–Selling Out data302,1428,04897 ALL OTHER MISCELLANEOUS04 VIT/MINERALS/NUTRIT.SUPPL52 INCONTINENCE CARE PRDS33 FIBRE FOOD PRODUCTS06 SKIN TREATMENT54 BABY DISPOSABLE & CH ENU31 DIABETIC FOOD PRODUCTS49 PLASTERS

点击免费查看完整报告